Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
-1.24M
-
Total reported value, excl. options
-
$59.1M
-
Value change
-
-$7.35M
-
Number of buys
-
28
-
Number of sells
-
-84
-
Price
-
$4.89
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q1 2024
133 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q1 2024.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 17.3M outstanding shares and own 70.07% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (1.66M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.55M shares), BlackRock Inc. (1.08M shares), VANGUARD GROUP INC (956K shares), Verition Fund Management LLC (792K shares), Solas Capital Management, LLC (749K shares), Alta Fundamental Advisers LLC (723K shares), Newtyn Management, LLC (500K shares), Prosight Management, LP (400K shares), and GEODE CAPITAL MANAGEMENT, LLC (365K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.